Table 1 Distribution of demographic/clinical traits by site and summary of PSQI scores
| 1A | ||||
|---|---|---|---|---|
| All Patients | Inpatients | Outpatients | Site Effect | |
| Demographic/Clinical | (n = 84) | (n = 42) | (n = 42) | (χ 2 , p) a |
|
Age in years (Mean; Range) | 62 (40-94) | 57(40-78) | 66(47-94) | 4.0, <0.01 |
| Sex (M:F)b | 65:19 | 23:19 | 42:00:00 | 24.6, <0.01 |
|
Cancer Stage (IIB:IIIA&B: IV)b | 1:18:65 | 0:10:32 | 1:08:33 | NS |
| Prior Therapy (Yes:No)b | 31:52 | 21:20 | 10:32 | NS |
| WHO ECOG (0:1:2)b | 30:42:11 | 17:18:07 | 13:24:04 | NS |
| COPD (No: Mild: Mod: Severe) | ND | ND | 14:7:13:8 | ND |
| 1B | ||||
| All Patients | Inpatients | Outpatients | Site Effect | |
| PSQI Sleep Factor | (n = 64) | (n = 37) | (n = 35) | (t, p ) a |
| Sleep Quality | 1.40 ± 0.11 | 1.23 ± 0.14 | 1.56 ± 0.16 | NS |
| Sleep Latency | 1.48 ± 0.12 | 1.46 ± 0.16 | 1.50 ± 0.18 | NS |
| Sleep Duration | 1.63 ± 0.14 | 1.62 ± 0.20 | 1.63 ± 0.20 | NS |
| Sleep Efficiency | 1.65 ± 0.16 | 1.57 ± 0.23 | 1.74 ± 0.21 | NS |
| Sleep Disturbance | 2.11 ± 0.12 | 1.80 ± 0.17 | 2.30 ± 0.15 | 5.6, 0.02 |
| Sleep Medication | 0.78 ± 0.12 | 0.81 ± 0.17 | 0.75 ± 0.17 | NS |
| Daytime Dysfunction | 1.34 ± 0.13 | 1.16 ± 0.16 | 1.52 ± 0.20 | NS |
| Global Sleep Quality Score | 11.19 ± 0.66 | 10.86 ± 0.93 | 11.54 ± 0.94 | NS |